Pharmaron Beijing (300759.SZ) Announces Increase in Issued A Shares

Bulletin Express

01/28

Pharmaron Beijing Co., Ltd. (300759.SZ) disclosed that on January 28, 2026, it issued a total of 81,643 A shares and 565,698 A shares under its 2021 and 2022 Restricted A Share Incentive Schemes, respectively. The issue prices were reported as RMB 30.39 per share and RMB 25.15 per share. According to the announcement, these issuance numbers are subject to final confirmation from the securities depository house in China.

Following the issuances, the total number of issued shares (excluding treasury shares) increased from 1,476,658,400 to 1,477,305,741. All relevant approvals related to these issuances were duly passed at earlier shareholders’ and class meetings, with details found in the company’s prior circulars and overseas regulatory announcements. The company indicated that it may revise the final issuance figures if an update is required.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1143099293"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143099293\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143099293?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143099293","market":"hk","top_or_hot":-1,"title":"Pharmaron Beijing (300759.SZ) Announces Increase in Issued A Shares","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (300759.SZ) disclosed that on January 28, 2026, it issued a total of 81,643 A shares and 565,698 A shares under its 2021 and 2022 Restricted A Share Incentive Schemes, respectively. The issue prices were reported as RMB 30.39 per share and RMB 25.15 per share. According to the announcement, these issuance numbers are subject to final confirmation from the securities depository house in China.</p>\n<p>Following the issuances, the total number of issued shares (excluding treasury shares) increased from 1,476,658,400 to 1,477,305,741. All relevant approvals related to these issuances were duly passed at earlier shareholders’ and class meetings, with details found in the company’s prior circulars and overseas regulatory announcements. The company indicated that it may revise the final issuance figures if an update is required.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing (300759.SZ) Announces Increase in Issued A Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing (300759.SZ) Announces Increase in Issued A Shares\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-01-28 17:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (300759.SZ) disclosed that on January 28, 2026, it issued a total of 81,643 A shares and 565,698 A shares under its 2021 and 2022 Restricted A Share Incentive Schemes, respectively. The issue prices were reported as RMB 30.39 per share and RMB 25.15 per share. According to the announcement, these issuance numbers are subject to final confirmation from the securities depository house in China.</p>\n<p>Following the issuances, the total number of issued shares (excluding treasury shares) increased from 1,476,658,400 to 1,477,305,741. All relevant approvals related to these issuances were duly passed at earlier shareholders’ and class meetings, with details found in the company’s prior circulars and overseas regulatory announcements. The company indicated that it may revise the final issuance figures if an update is required.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龍化成","start_time":0,"source_url":"","article_id":"1143099293","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143099293","pubTimestamp":1769593388,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (300759.SZ) disclosed that on January 28, 2026, it issued a total of 81,643 A shares and 565,698 A shares under its 2021 and 2022 Restricted A Share Incentive Schemes,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成北京（300759.SZ）公告增持已发行A股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (300759.SZ) disclosed that on January 28, 2026, it issued a total of 81,643 A shares and 565,698 A shares under its 2021 and 2022 Restricted A Share Incentive Schemes, respectively. The issue prices were reported as RMB 30.39 per share and RMB 25.15 per share. According to the announcement, these issuance numbers are subject to final confirmation from the securities depository house in China.\nFollowing the issuances, the total number of issued shares (excluding treasury shares) increased from 1,476,658,400 to 1,477,305,741. All relevant approvals related to these issuances were duly passed at earlier shareholders’ and class meetings, with details found in the company’s prior circulars and overseas regulatory announcements. The company indicated that it may revise the final issuance figures if an update is required.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}